News

Aspen Aerogels Plans Earnings Call for Q1 2025 Conference

Aspen Aerogels Plans Earnings Call for Q1 2025 Conference

Aspen Aerogels Announces Q1 2025 Earnings Call

Aspen Aerogels, Inc. (NYSE: ASPN), recognized for its groundbreaking work in aerogel technology, has scheduled a pivotal conference call to discuss its financial results for the first quarter of 2025. This event is set to take place on a Thursday morning, where key executives will share insights and updates.

Details of the Conference Call

On this anticipated call, Don Young, the President and Chief Executive Officer, along with Ricardo C. Rodriguez, the Chief Financial Officer and Treasurer, will provide insights into the company’s financial performance. The call is slated to begin at 8:30 a.m. ET, where the executives will detail the results from the quarter ending on March 31, 2025. Additionally, the company plans to release these financial results just before the market opens that same morning.

How to Participate

Those interested in tuning into the conference call can do so by dialing the designated phone numbers for both domestic and international participants. It is recommended to join a few minutes prior to the call to ensure a smooth start. Moreover, attendees can look forward to an accompanying slide presentation that will be available via a live webcast.

Webcast and Replay Options

For those who cannot attend live, a replay of the webcast will be accessible on the Investor Relations section of Aspen's website. This provides a valuable opportunity for all stakeholders to engage with the content, even after the event concludes.

About Aspen Aerogels, Inc.

Aspen Aerogels, Inc. stands at the forefront of sustainability and electrification solutions. The company’s innovative aerogel technology is designed to empower customers and partners to address critical global challenges such as energy efficiency, electric mobility, and sustainable energy practices. Aspen’s PyroThin® products play a crucial role in managing thermal runaway issues in electric vehicles, while the carbon aerogel initiative focuses on enhancing the performance of lithium-ion battery cells, promoting faster charging and lower costs in the EV sector.

Furthermore, the company’s Cryogel® and Pyrogel® offerings are recognized and appreciated by major players in the energy infrastructure sphere. Aspen’s strategic approach emphasizes collaboration with esteemed industry leaders to extend its Aerogel Technology Platform® into high-value markets, showcasing its commitment to innovation and industry advancements.

Conclusion and Future Direction

As Aspen Aerogels moves forward, the company remains dedicated to its vision of a sustainable and electrified future. The upcoming call represents an essential moment for stakeholders to gain insights into the ongoing projects and future directions that the company is pursuing. With robust engagement in the development of sustainable solutions, Aspen Aerogels is well-positioned to be a significant enabler in the transition to a low-carbon future.

Frequently Asked Questions

1. What is the purpose of the conference call scheduled for May 8, 2025?

The conference call is intended to discuss Aspen Aerogels' financial results for the first quarter of 2025.

2. Who will be presenting during the earnings call?

The call will feature Don Young and Ricardo C. Rodriguez, who will share insights about the company's financial performance.

3. How can I listen to the conference call?

You can participate by dialing the designated phone numbers or access the live webcast on the Investor Relations section of Aspen's website.

4. Can I access a replay of the conference call?

Yes, a replay will be available on Aspen's website for approximately one year after the event.

5. What technologies does Aspen Aerogels focus on?

Aspen Aerogels emphasizes sustainability and electrification solutions, including aerogel technology for electric vehicles and energy infrastructure.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 513

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Applied Materials: Navigating Earnings Signals and Market Trends

Updated Category News Views 180

Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...

Continue Reading
Transforming Money for the Digital Age with Lightspark

Updated Category News Views 363

Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...

Continue Reading
XploraDEX Token Launch Sets New Stage for DeFi Innovation

Updated Category News Views 184

Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...

Continue Reading
Empire Development Unveils Luxurious Real Estate Offerings

Updated Category News Views 253

Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...

Continue Reading
Biden's Final Moves: Key Actions Before Transitioning Power

Updated Category News Views 169

Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...

Continue Reading